niacinamide and tacrolimus

niacinamide has been researched along with tacrolimus in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (33.33)	29.6817
2010's	6 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Hashii, M; Higashida, H; Minabe, Y	1
Rosenkrantz, WS	1
Igarashi, H; Katayama, Y	1
Düber, C; Galle, PR; Heise, M; Hoppe-Lotichius, M; Koch, S; Niederle, IM; Otto, G; Schuchmann, M; Weinmann, A; Wörns, MA	1
Dawidowski, M; Gajzlerska, W; Gutkowska, B; Klimaszewska, M; Król, M; Turło, J	1
Lehner, GM; Linek, M	1
Banovic, F; Howerth, E; Jerry, C	1
Cao, S; Ruan, W; Wan, T; Wang, Y; Wu, C; Xu, Y; Yu, K; Zhai, Y	1

Reviews

2 review(s) available for niacinamide and tacrolimus

Article	Year
Pemphigus: current therapy. Veterinary dermatology, 2004, Volume: 15, Issue:2 Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline	2004
[Advances in the diagnosis and treatment of cerebral ischemia during the acute phase]. Rinsho shinkeigaku = Clinical neurology, 2003, Volume: 43, Issue:11 Topics: Acute-Phase Reaction; Antipyrine; Brain Ischemia; Cerebrovascular Circulation; Drug Design; Drug Therapy, Combination; Edaravone; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Nerve Growth Factors; Neuroprotective Agents; Niacinamide; Recombinant Proteins; Tacrolimus; Time Factors; Tissue Plasminogen Activator	2003

Article

Year

Pemphigus: current therapy.

Veterinary dermatology, 2004, Volume: 15, Issue:2

Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline

2004

[Advances in the diagnosis and treatment of cerebral ischemia during the acute phase].

Rinsho shinkeigaku = Clinical neurology, 2003, Volume: 43, Issue:11

Topics: Acute-Phase Reaction; Antipyrine; Brain Ischemia; Cerebrovascular Circulation; Drug Design; Drug Therapy, Combination; Edaravone; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Nerve Growth Factors; Neuroprotective Agents; Niacinamide; Recombinant Proteins; Tacrolimus; Time Factors; Tissue Plasminogen Activator

2003

Other Studies

7 other study(ies) available for niacinamide and tacrolimus

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
cADP-ribose potentiates cytosolic Ca2+ elevation and Ca2+ entry via L-type voltage-activated Ca2+ channels in NG108-15 neuronal cells. The Biochemical journal, 2000, Jan-15, Volume: 345 Pt 2 Topics: Adenosine Diphosphate Ribose; Biological Transport; Calcium; Calcium Channels, L-Type; Cells, Cultured; Cyclic ADP-Ribose; Cytosol; Ion Channel Gating; Manganese; Membrane Potentials; Models, Biological; NAD; Neurons; Niacinamide; Nifedipine; Patch-Clamp Techniques; Ryanodine; Ryanodine Receptor Calcium Release Channel; Tacrolimus	2000
Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Female; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Pyridines; Retrospective Studies; Sirolimus; Sorafenib; Tacrolimus	2012
Enhancement of tacrolimus productivity in Streptomyces tsukubaensis by the use of novel precursors for biosynthesis. Enzyme and microbial technology, 2012, Dec-10, Volume: 51, Issue:6-7 Topics: Biotechnology; Culture Media; Fermentation; Kinetics; NAD; NADP; Niacin; Niacinamide; Picolinic Acids; Streptomyces; Tacrolimus	2012
A case of vesicular cutaneous lupus erythematosus in a Border collie successfully treated with topical tacrolimus and nicotinamide-tetracycline. Veterinary dermatology, 2013, Volume: 24, Issue:6 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Combinations; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Male; Niacinamide; Tacrolimus; Tetracycline; Vitamin B Complex	2013
Tacrolimus therapy for dermal arteritis of the nasal philtrum refractory to surgery and anti-inflammatory therapy (doxycycline/niacinamide and topical fluocinolone) in a dog. Veterinary dermatology, 2018, Volume: 29, Issue:1 Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Arteritis; Dog Diseases; Dogs; Doxycycline; Fluocinolone Acetonide; Lip; Male; Niacinamide; Nose; Tacrolimus	2018
Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. International journal of nanomedicine, 2018, Volume: 13 Topics: Administration, Cutaneous; Animals; Chitosan; Dermatitis, Atopic; Dinitrochlorobenzene; Drug Delivery Systems; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Niacinamide; Ointments; Rats, Sprague-Dawley; Skin; Skin Absorption; Tacrolimus; Treatment Outcome	2018